Yahoo India Web Search

Sign In

Search results

  2. People also ask

  3. www.lalpathlabs.com › pdf › Earning-Presentation-Q4Dr. Lal PathLabs Limited (DLPL) Q4 FY22 Results Presentation

    Note: Revenue in Q4 22 includes Rs 46 Cr (Non Covid 29.4 Cr, Covid Rs 16.6 Cr) and Q3 22 includes Rs. 49.1 Cr (Non Covid 24.6 Cr, Covid Rs 24.5 Cr) of Suburban wef 12 th

  4. www.lalpathlabs.com › pdf › Audited-Financial-ResultDr Lal PathLabs

    Dr Lal PathLabs

  5. Videos

    View all

  6. alphastreet.com › india › research-summary-dr-lalResearch Summary Dr Lal PathLabs Limited Q4 FY 2022

    Jul 1, 2022 · For FY22, Dr Lal PathLabs Limited has served 27.3 million patients with a revenue of Rs 2,087 crores. In Q4 FY22 the non-COVID revenue is Rs 419.7 crores with a registered growth of 12.2%. For FY22, non-COVID revenue is Rs 1,691 crore, registering a growth of 34.5%.Covid and Allied contributed 13.6% to revenue in Q4 FY22.

  7. www.lalpathlabs.com › investor › quarterly-resultsQuarterly Results - Dr Lal PathLabs

    Results for Quarter & Half Year ended September 30, 2019. Press Release. Press Release – Q2 H1 FY20. Earnings Presentation. Earnings Presentation – Q2 H1 FY20. Unaudit Financial Results. Unaudited Financial Results – Q2 H1 & FY20. Analyst Concall Transcript. Analyst Concall Transcript – Q2 H1 FY20.

  8. alphastreet.com › india › dr-lal-pathlabs-ltdDr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall ...

    May 17, 2022 · Revenue for Q4 FY ’22 is Rs. 486 crores as compared to Rs. 431 crores in last year same quarter, a growth of 12.7%. Non-COVID revenue increased by 12.2% in Q4 FY ’22. Revenue for full year FY ’22 is Rs. 2,087 crores as compared to Rs. 1,581 crores in the last year, a growth of 32%. Non-COVID revenue for full year increased by 34.5%.

  9. economictimes.indiatimes.com › markets › stocksDr Lal Pathlabs Q4 Results: Profit dips 27% to Rs 62 cr

    May 17, 2022 · Dr Lal Pathlabs on Tuesday said its consolidated net profit declined 27 per cent to Rs 62 crore in the fourth quarter ended March 31, 2022. The company had reported a net profit of Rs 85 crore for January-March period a year ago.

  10. archives.nseindia.com › corporate › LALPATHLABSub: Press Release on Audited Financial Results (Standalone ...

    Dr Lal PathLabs Limited records revenue of Rs 491 Cr in Q4 FY 2022-23. New Delhi, India, May 11, 2023 – Dr Lal PathLabs Limited (referred to as the “Company”; NSE: LALPATHLAB, BSE: 539524), a leading diagnostic and related healthcare service provider announces their financial results for the quarter ended March 31, 2023. .